US Stock MarketDetailed Quotes

Olema Pharmaceuticals (OLMA)

Watchlist
  • 9.500
  • +0.310+3.37%
Trading Jun 17 14:38 ET
829.80MMarket Cap-4.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Olema Pharmaceuticals (OLMA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
66.28%57.99M
25.62%178.7M
36.22%50.08M
21.95%45.88M
42.75%47.86M
1.56%34.87M
35.53%142.26M
20.88%36.77M
61.17%37.62M
55.22%33.53M
Selling and administrative expenses
106.02%8.75M
18.38%21M
53.59%6.86M
34.84%5.93M
-10.38%3.96M
-4.65%4.25M
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
-General and administrative expense
106.02%8.75M
18.38%21M
53.59%6.86M
34.84%5.93M
-10.38%3.96M
-4.65%4.25M
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
Research and development costs
60.76%49.23M
26.65%157.7M
33.81%43.22M
20.24%39.95M
50.82%43.9M
2.48%30.62M
44.55%124.52M
24.84%32.3M
70.80%33.23M
61.82%29.11M
Operating profit
-66.28%-57.99M
-25.62%-178.7M
-36.22%-50.08M
-21.95%-45.88M
-42.75%-47.86M
-1.56%-34.87M
-35.53%-142.26M
-20.88%-36.77M
-61.17%-37.62M
-55.22%-33.53M
Net non-operating interest income expense
5.57%4.78M
27.93%16.22M
21.74%4.01M
24.59%3.65M
30.05%4.04M
34.96%4.52M
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
Non-operating interest income
5.57%4.78M
27.93%16.22M
21.74%4.01M
24.59%3.65M
30.05%4.04M
34.96%4.52M
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
Other net income (expense)
402.50%121K
-77.45%23K
113.98%13K
-91.30%12K
-5.00%38K
-335.29%-40K
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
Other non- operating income (expenses)
402.50%121K
-77.45%23K
113.98%13K
-91.30%12K
-5.00%38K
-335.29%-40K
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
Income before tax
-74.70%-53.09M
-25.47%-162.45M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
Income tax
Net income
-74.70%-53.09M
-25.47%-162.45M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
Net income continuous Operations
-74.70%-53.09M
-25.47%-162.45M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
Minority interest income
Net income attributable to the parent company
-74.70%-53.09M
-25.47%-162.45M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-74.70%-53.09M
-25.47%-162.45M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
Basic earnings per share
-44.44%-0.52
15.00%-1.87
-27.50%-0.51
18.33%-0.49
5.56%-0.51
35.71%-0.36
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
Diluted earnings per share
-44.44%-0.52
15.00%-1.87
-27.50%-0.51
18.33%-0.49
5.56%-0.51
35.71%-0.36
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 66.28%57.99M25.62%178.7M36.22%50.08M21.95%45.88M42.75%47.86M1.56%34.87M35.53%142.26M20.88%36.77M61.17%37.62M55.22%33.53M
Selling and administrative expenses 106.02%8.75M18.38%21M53.59%6.86M34.84%5.93M-10.38%3.96M-4.65%4.25M-5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M
-General and administrative expense 106.02%8.75M18.38%21M53.59%6.86M34.84%5.93M-10.38%3.96M-4.65%4.25M-5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M
Research and development costs 60.76%49.23M26.65%157.7M33.81%43.22M20.24%39.95M50.82%43.9M2.48%30.62M44.55%124.52M24.84%32.3M70.80%33.23M61.82%29.11M
Operating profit -66.28%-57.99M-25.62%-178.7M-36.22%-50.08M-21.95%-45.88M-42.75%-47.86M-1.56%-34.87M-35.53%-142.26M-20.88%-36.77M-61.17%-37.62M-55.22%-33.53M
Net non-operating interest income expense 5.57%4.78M27.93%16.22M21.74%4.01M24.59%3.65M30.05%4.04M34.96%4.52M52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M
Non-operating interest income 5.57%4.78M27.93%16.22M21.74%4.01M24.59%3.65M30.05%4.04M34.96%4.52M52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M
Other net income (expense) 402.50%121K-77.45%23K113.98%13K-91.30%12K-5.00%38K-335.29%-40K636.84%102K-200.00%-93K274.68%138K190.91%40K
Other non- operating income (expenses) 402.50%121K-77.45%23K113.98%13K-91.30%12K-5.00%38K-335.29%-40K636.84%102K-200.00%-93K274.68%138K190.91%40K
Income before tax -74.70%-53.09M-25.47%-162.45M-37.22%-46.06M-22.17%-42.22M-44.11%-43.78M1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M
Income tax
Net income -74.70%-53.09M-25.47%-162.45M-37.22%-46.06M-22.17%-42.22M-44.11%-43.78M1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M
Net income continuous Operations -74.70%-53.09M-25.47%-162.45M-37.22%-46.06M-22.17%-42.22M-44.11%-43.78M1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M
Minority interest income
Net income attributable to the parent company -74.70%-53.09M-25.47%-162.45M-37.22%-46.06M-22.17%-42.22M-44.11%-43.78M1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -74.70%-53.09M-25.47%-162.45M-37.22%-46.06M-22.17%-42.22M-44.11%-43.78M1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M
Basic earnings per share -44.44%-0.5215.00%-1.87-27.50%-0.5118.33%-0.495.56%-0.5135.71%-0.36-2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.54
Diluted earnings per share -44.44%-0.5215.00%-1.87-27.50%-0.5118.33%-0.495.56%-0.5135.71%-0.36-2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +35.38%
Sample Name
Sample Code
 +23.42%
Sample Name
Sample Code
 -10.82%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-12.19%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-15.53%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.70%
Sample Name
Sample Code
 +11.68%
Sample Name
Sample Code
 +7.52%
4
Amer Sports
AS
+6.40%
5
Futu Holdings Ltd
FUTU
+5.06%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On Tuesday, Trump stated that the United States and Iran had successfully signed a memorandum of understanding online, and that their negoti Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -